Clinical Trial Update: Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing dacarbazine and/or cisplatin with complete metastasectomy for stage IV melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Dacarbazine (dacarbazine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma (Skin) | Phase 3 | Status: COMPLETED